Antidiabetic drugs restore abnormal transport of amyloid-β across the blood–brain barrier and memory impairment in db/db mice
- 1 February 2016
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 101, 123-136
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81273497)
- Priority Academic Program Development of Jiangsu Higher Education Institutions
This publication has 57 references indexed in Scilit:
- Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearanceProceedings of the National Academy of Sciences, 2013
- Advanced Glycation End Products Induce Peroxisome Proliferator-Activated Receptor γ Down-Regulation-Related Inflammatory Signals in Human Chondrocytes via Toll-Like Receptor-4 and Receptor for Advanced Glycation End ProductsPLOS ONE, 2013
- Diabetes mellitus as a modulator of functional impairment and decline in Alzheimer’s disease. The Real.FR cohortDiabetic Medicine, 2012
- Deficient brain insulin signalling pathway in Alzheimer's disease and diabetesThe Journal of Pathology, 2011
- Effect of alogliptin, pioglitazone and glargine on pancreatic β-cells in diabetic db/db miceBiochemical and Biophysical Research Communications, 2011
- Brain Insulin Impairs Amyloid-β(1-40) Clearance from the BrainThe Journal of Neuroscience, 2004
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003
- Adipocyte Low Density Lipoprotein Receptor-related Protein Gene Expression and Function Is Regulated by Peroxisome Proliferator-activated Receptor γJournal of Biological Chemistry, 2003
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer typeJournal of Neural Transmission, 1989